EPO Patents = 5

Forward Citations = 0

Loading Chart...

6 inventors (with patents filed for the assignee):

Michel Janicot (6 out of 6 patents)

Eugen Uhlmann (5 out of 80 patents)

Frank Jaschinski (5 out of 12 patents)

4. Eugen Leo (3 out of 3 patents)

5. Katja Wosikowski-Buters (1 out of 1 patent)

6. Petra Fettes (1 out of 1 patent)

7. Anneliese Schneider (3 patents)

8. Karl-Hermann Schlingensiepen (14 patents)

9. Reimar Schlingensiepen (0 patent)

10. Tanja Rothammer (0 patent)

6 patents: Sort by Forward Citations

1. 11207341 - TGF-beta oligonucleotide for use in treatment of ophthalmic diseases (2021-12-28),

2. 10538768 - Modified TGF-beta oligonucleotides (2020-01-21),

3. 10125368 - Modified TGF-beta oligonucleotide for use in a method of preventing and/or treating an ophthalmic disease (2018-11-13),

4. 9926563 - Modified TGF-beta oligonucleotides (2018-03-27),

5. 9840707 - Modified TGF-beta2 oligonucleotides (2017-12-12),

6. 9688988 - Modified TGF-beta oligonucleotide for use in a method of preventing and/or treating an ophthalmic disease (2017-06-27),

Company Overview

Isarna Therapeutics is a clinical-stage biotech company focused on developing innovative TGF-beta immunotherapies to treat cancer. The company's platform technology allows for the specific silencing of TGF-beta isoforms, disrupting the tumor microenvironment to enhance the anti-tumor immune response. Isarna Therapeutics aims to improve outcomes for cancer patients by leveraging the potential of TGF-beta modulation in oncology.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

6 Patents

#269 in W-8000 Munich

#5,405 in Germany

Munich, Germany

Isarna Therapeutics Gmbh

Forward Citations = 0

6 inventors:

Michel Janicot (6 out of 6 patents)

Eugen Uhlmann (5 out of 80 patents)

Frank Jaschinski (5 out of 12 patents)

4. Eugen Leo (3 out of 3 patents)

5. Katja Wosikowski-Buters (1 out of 1 patent)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Isarna Therapeutics Gmbh. Retrieved from https://idiyas.com/company/isarna-therapeutics

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

5 patents (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]